HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Myeloma Innovation in 2023 - An Annual Review
Myeloma Innovation in 2023 - An Annual Review image
HealthTree Podcast for Multiple Myeloma
event Jan 17, 2023 / 02:30PM - 03:45PM CST

Event Description


There are significant advances being made in multiple myeloma - more so than in any other cancer. Join us for this annual HealthTree Podcast for Multiple Myeloma with Robert Orlowski, MD, PhD of MD Anderson Cancer Center as we discuss the recent findings from the American Society of Hematology (ASH) meeting, key innovations being developed in myeloma and what patients can expect to see in 2023.

The show will review immunotherapy options, optimal combination therapies, targeted treatments and key learnings from top myeloma investigators.  

Thanks to our episode sponsor, GSK

We appreciate your donations to support the HealthTree Foundation Podcast.


Schedule & Agenda

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Welcome, Announcements & Introduction

The panelist Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhD

A discussion with Robert Orlowski, MD, PhD including a review for 2023 of upcoming innovations for myeloma patients. 

The panelist Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhD

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. Orlowski questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Robert Orlowski, MD, PhD
Robert Orlowski, MD, PhD

Robert Z. Orlowski, M.D., Ph.D., is Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics, where he is board-certified in medical oncology. Dr. Orlowski earned his doctoral degree in molecular biophysics and biochemistry from Yale University and his medical degree from the Yale University School of Medicine. He completed his internship and residency in Internal Medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine. After his fellowships in Hematology and Medical Oncology at John Hopkins Sidney Kimmel Comprehensive Cancer Center, he joined the faculty at University of North Carolina in Chapel Hill. Following that, Dr. Orlowski accepted a position at The University of Texas MD Anderson Cancer Center in 2007 to lead the Myeloma Section in the Department of Lymphoma/Myeloma. His research interests include pathobiology of, novel therapeutic targets and mechanisms of drug resistance in myeloma which are documented in hundreds of scientific articles, book chapters, and presentations at conferences. Dr. Orlowski is an investigator on numerous clinical trials, and appointed Myeloma Committee Chair for SWOG.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube